I've run a psychedelic therapy naturalistic study comparing two treatments. Both post-psychedelic interventions are ACT-consistent but one has imaginal exposure to the psychedelic memory and related aversive events.
We have 30 participants with enough data to run S-GIMME. I read in one paper that 25 participants were the minimum number. We found 2 subgroups with different green subgroup pathways. They phi correlate with treatment 0.550 (p=0.003) (95% CI - Lower (.019), Higher (0.85) Valid cases n=30.
The subgroups plot shows that the exceptions to the correlation are usually just over the border between subgroups, suggesting that subgroup plot shows two clear clusters that overlap.
To try and get a clearer view of how GIMME could be used to measure variation in psychological processes according to treatment, we decided to try a split GIMME (without subgroups) on each treatment group. One treatment group n=20 is twice the size of the other treatment group (n=10).
My principle question is whether this is a good move or not? Is the fact that both groups are now both less than 25 participants a problem?
I notice that the filtering of signal from noise is quite different without the subgroup level. Both group and individual models change on the same dataset.
GIMME (without subgroups) detected a group pathway for one treatment (n=10), and no group pattern for the other treatment group (n=20). So arguably this method does detect different effects. However these group patterns are very different from the n=30 S-GIMME group (thick black) pattern.
Is this still a meaningful way of differentiating treatment effects in the longitudinal GIMME data?
Many thanks,
Henry Whitfield